A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years
Clinical trial NCT06210737 · COMPLETED
Trial details
- NCT number
- NCT06210737
- Sponsor
- Beijing Minhai Biotechnology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2022-11-13
- Enrollment
- 621
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.